Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metastases from solid tumors: A prospective multicentre translational analysis of the BrainStorm (OncoDistinct-006) study
Publication date: December 2026 Source: The Journal of Liquid Biopsy, Volume 14 Author(s): Luca Arecco, Françoise Rothé, David Venet, Andrea Gombos, Anthony Gonçalves, Eleonora De Maio D'Esposito, Philippe Barthélémy, Vincent Vanhaudenarde, Florian Clatot, Stephane Holbrechts, Francois P. Duhoux, Edith Borcoman, Claire Cheymol, Joseph Gligorov, Hannelore Denys, Paul M. Clement, Kevin Punie, Caroline Duhem, Lore Decoster, Jean-Luc Canon
Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metastases from solid tumors: A prospective multicentre translational analysis of the BrainStorm (OncoDistinct-006) study. // The Journal of Liquid Biopsy. – URL: https://www.sciencedirect.com/science/article/pii/S295019542600038X?dgcid=rss_sd_all
Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metastases from solid tumors: A prospective multicentre translational analysis of the BrainStorm (OncoDistinct-006) study. The Journal of Liquid Biopsy. https://www.sciencedirect.com/science/article/pii/S295019542600038X?dgcid=rss_sd_all
“Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metastases from solid tumors: A prospective multicentre translational analysis of the BrainStorm (OncoDistinct-006) study.” The Journal of Liquid Biopsy.
@article{article68007,
title = {Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metastases from solid tumors: A prospective multicentre translational analysis of the BrainStorm (OncoDistinct-006) study},
journal = {The Journal of Liquid Biopsy},
url = {https://www.sciencedirect.com/science/article/pii/S295019542600038X?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment